HRPC(600829)2024-09-26 09:12Group 1: Company Overview - The company is primarily engaged in pharmaceutical wholesale, retail, and related services [1] - The company has a development history, main business operations, and a management team that were introduced during the investor meeting [1] Group 2: Financial Performance - In the first half of 2024, the company achieved a revenue of CNY 4.986 billion, representing a growth of 5.49% [1] - The net profit for the same period was CNY 135 million, showing a year-on-year decline of 11.84% [1] Group 3: Business Development - The company currently operates 15 DTP (Direct-to-Patient) specialty pharmacies in Heilongjiang Province, focusing on oncology and immunotherapy medications [1] - The growth in the retail segment is primarily attributed to the expansion of the DTP business [1]